Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancer

BACKGROUND: Standard chemoradiotherapy (CRT) using cisplatin (CDDP) and 5-fluorouracil (5-FU) is an optional treatment for patients with stage II-III esophageal cancer. However, there are some demerits in this regimen because CDDP administration requires a large transfusion volume and 5-FU must be c...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamashita, Hideomi, Haga, Akihiro, Takenaka, Ryousuke, Kiritoshi, Tomoki, Okuma, Kae, Ohtomo, Kuni, Nakagawa, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717830/
https://www.ncbi.nlm.nih.gov/pubmed/26781439
http://dx.doi.org/10.1186/s13014-016-0587-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717830/
https://www.ncbi.nlm.nih.gov/pubmed/26781439
http://dx.doi.org/10.1186/s13014-016-0587-9

Ejemplares similares